Arena Pharmaceuticals, Inc. (ARNA) Consensus Price Target The company’s consensus rating on Reuter’s scale slipped from 2.43 to 2.25 during a month. Analysts set a 12-month price target of $35.5 a share. The target implies a 110.43% spike from where the shares are currently trading. Also, the current price highlights a discount of 196.38% to analysts’ high consensus price target.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Intraday Trading The counter witnessed a trading volume of 0.75 million shares versus an average volume of 0.35 million shares during last trading session. Its last month’s stock price volatility remained 7.44% which for the week approaches 7.22%. The lowest price the stock reached in the last trading day was $15.97 and compares with the $11.3 52-week low. The stock recovered 49.29% since its low point and has performed 18.8% year-to-date.
For direct communication email me futurebankruptcy at gmail dot com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.